Royal Bank Of Canada Nu Cana PLC Transaction History

Royal Bank Of Canada

  • $471 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$0.76 - $1.69 $380 - $845
500 New
500 $0
Q4 2021

Feb 14, 2022
SELL
$2.02 - $2.9 $381 - $548
-189 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$1.95 - $2.85 $633 - $926
-325 Reduced 63.23%
189 $0
Q2 2021

Aug 16, 2021
BUY
$2.7 - $5.04 $1,387 - $2,590
514 New
514 $1,000

Others Institutions Holding NCNA

# of Institutions
1
Shares Held
3.33M
Call Options Held
0
Put Options Held
0
View Full List

About NuCana plc

NCNA Quotes by TradingView
  • Ticker NCNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,196,000
  • Market Cap $59M
  • Description
  • NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...
More about NCNA
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email